Literature DB >> 17302063

[Regulatory effect of Chinese herbal compound for detoxifying and activating blood circulation on expression of NF-kappaB and MMP-9 in aorta of apolipoprotein E gene knocked-out mice].

Jing-chun Zhang1, Ke-ji Chen, Guang-juan Zheng.   

Abstract

OBJECTIVE: To observe the regulatory effect of Chinese herbal compound for detoxifying and activating blood circulation on expression of nuclear factor-kappaB (NF-kappaB) and matrix metalloproteinase-9 (MMP-9) in aorta of apolipoprotein E gene knocked-out (ApoE (-/-)) mice.
METHODS: ApoE (-/-) mice of 13-week old were divided into two groups and fed with normal diet (Group A) and hyperlipidemic diet (Group B) respectively, the latter was subdivided into 7 groups as Group B1 - 7. Besides, a normal control group was set up with C57BL/6J mice. The drugs used for intervention were polydatin (PD, with 26.6 mg/kg as one dose) for detoxifying and Xiongshao Capsule (XC, with 110 mg/kg as one dose) for activating blood circulation respectively. The intervention was started 19 weeks later by treated Group B1 with PD one dose daily, Group B2 with XC one dose daily, Group B3 with PD and XC each 2 doses daily, Group B4 with PD and XC each one dose daily, Group B5 with PD and XC each half dose daily, Group B6 with lovastatin. To the Group B 7 (as a hyperlipidemia model group) as well as Group A and the normal control group, normal saline was given. After 17 weeks of intervention, the expressions of NF-kappaB and MMP-9 in aorta of mice were determined with immunohistochemical assay.
RESULTS: Expressions of NF-kappaB and MMP-9 in aorta and sclerotic plaque were higher in group B7 than those in the normal control group, which were lowered in group B1 - 6 (P < 0.01), and the optimal effect was shown in group B3 (P <0.01).
CONCLUSION: Combined use of Chinese herbal medicine for detoxifying and activating blood circulation could reduce expression of NF-kappaB and MMP-9 in aorta of ApoE (-/-) mice, and the effect of the combination of the two was superior to that of use either of them.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17302063

Source DB:  PubMed          Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi        ISSN: 1003-5370


  6 in total

1.  Effect of Chinese drugs for activating blood circulation and detoxifying on indices of thrombosis, inflammatory reaction, and tissue damage in a rabbit model of toxin-heat and blood stasis syndrome.

Authors:  Mei Xue; Hui-Jun Yin; Cai-Feng Wu; Xiao-Juan Ma; Chun-Yu Guo; Ye Huang; Da-Zhuo Shi; Ke-Ji Chen
Journal:  Chin J Integr Med       Date:  2011-12-08       Impact factor: 1.978

2.  Effect of removing toxic substances combined with activating blood circulation on stabilizing the atherosclerotic plaque and unstable angina.

Authors:  Wen-gao Zhang
Journal:  Chin J Integr Med       Date:  2009-10-03       Impact factor: 1.978

3.  Effect of chinese herbal drug-containing serum for activating-blood and dispelling-toxin on ox-LDL-induced inflammatory factors' expression in endothelial cells.

Authors:  Yue-Rong Jiang; Yu Miao; Lin Yang; Mei Xue; Chun-Yu Guo; Xiao-Juan Ma; Hui-Jun Yin; Da-Zhuo Shi; Ke-Ji Chen
Journal:  Chin J Integr Med       Date:  2011-10-12       Impact factor: 1.978

4.  Effect of Chinese herbal medicine for activating blood circulation and detoxifying on expression of inflammatory reaction and tissue damage related factors in experimental carotid artery thrombosis rats.

Authors:  Mei Xue; Lu Zhang; Lin Yang; Yue-rong Jiang; Chun-yu Guo; Hui-jun Yin; Ke-ji Chen
Journal:  Chin J Integr Med       Date:  2010-08-08       Impact factor: 1.978

Review 5.  Clinical significance of inflammation factors in acute coronary syndrome from pathogenic toxin.

Authors:  Yan Feng; Jing-chun Zhang; Rui-xi Xi
Journal:  Chin J Integr Med       Date:  2009-08-18       Impact factor: 1.978

6.  ITIH4: A New Potential Biomarker of "Toxin Syndrome" in Coronary Heart Disease Patient Identified with Proteomic Method.

Authors:  Hao Xu; Qinghua Shang; Hao Chen; Jianpeng Du; Jianyan Wen; Geng Li; Dazhuo Shi; Keji Chen
Journal:  Evid Based Complement Alternat Med       Date:  2013-08-19       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.